The simple act of filling a prescription has become, for millions of Americans, a frustrating obstacle course. It’s a problem that transcends insurance plans and geographic boundaries, and it’s costing patients time, money, and potentially, their health. At the heart of the issue lies a decades-old practice known as “prior authorization,” a process where insurance companies require doctors to obtain approval before prescribing certain medications or treatments. While initially intended to curb costs, prior authorization has morphed into a system riddled with delays, denials, and administrative burdens that many experts now describe as a significant barrier to care.
For many, the process begins with a phone call – often lengthy and repetitive – to their insurance provider. Even seemingly straightforward requests for commonly prescribed medications can be met with resistance. The delays aren’t merely inconvenient; they can exacerbate existing conditions, lead to hospitalizations, and undermine the doctor-patient relationship. The core of the problem isn’t about denying necessary care, but about creating enough friction that patients grant up, or doctors simply prescribe alternative treatments, not always the *best* treatments, but the ones most likely to be approved.
The Origins of a Complicated System
Prior authorization didn’t begin as a malicious scheme. Its roots trace back to the 1973 Health Maintenance Organization Act, designed to control healthcare spending. Initially, the practice was reserved for expensive procedures and lengthy hospital stays. As enrollment in Health Maintenance Organizations (HMOs) grew in subsequent decades, so did the number of services subject to prior authorization. Insurers created their own unique portals and requirements, placing an increasing administrative burden on physicians. The Affordable Care Act, while expanding access to insurance, didn’t alleviate the problem and, in some cases, arguably exacerbated it, according to a 2022 report by the American Medical Association. The AMA has been a vocal critic of prior authorization for years.
The Financial Toll on Patients and Providers
The costs associated with prior authorization extend far beyond the price of the medication itself. A 2021 study published in Health Affairs estimated that physicians and their staff spend approximately
The impact on patient health is equally concerning. A survey of New York State physicians revealed that more than 40% reported delays related to prior authorization had led to “serious adverse outcomes” for a patient, and nearly 50% said delays had caused patients to abandon treatment altogether. These delays aren’t limited to complex or experimental therapies; they frequently affect access to essential, generic medications for chronic conditions like asthma, diabetes, and heart disease.
A System Designed to Deny?
Critics argue that the current system incentivizes denial. Insurance companies profit by delaying or denying care, shifting the financial burden onto patients and providers. The appeal process is often cumbersome and time-consuming, discouraging many from pursuing it. In fact, a recent study by the Kaiser Family Foundation (KFF) found that only 1 in 10 prior authorization denials were appealed in 2022. KFF’s research highlights the significant barriers patients face when challenging insurance decisions.
“I always tell my patients now that when I write a prescription, I consider it a recommendation because I don’t know what’s going to be filled,” said David Aizuss, Chair of the American Medical Association, during a House hearing on healthcare affordability last month. “We have to go through a prior authorization process frequently to get basic, long-standing generic drugs approved so that I can treat my patients’ glaucoma or whatever the problem may be.”
Legislative Efforts to Reform Prior Authorization
Recognizing the growing frustration and the detrimental effects of prior authorization, lawmakers are beginning to capture action. The “Doctor Knows Best Act” aims to eliminate prior authorization requirements for most medical services, including prescription drugs, arguing that physicians are best equipped to make decisions about patient care. The bill would prohibit health insurance plans from interfering with those decisions unless there is a clear and compelling medical reason to do so.
A related issue, “step therapy,” also faces scrutiny. Step therapy requires patients to try less expensive medications first, even if their doctor believes a different medication is more appropriate. This practice can lead to unnecessary suffering and delayed relief. Advocates for reform argue that both prior authorization and step therapy prioritize cost-cutting over patient well-being.
What’s Next?
The future of prior authorization remains uncertain. The Doctor Knows Best Act has gained some traction in Congress, but faces opposition from insurance industry lobbyists. The debate highlights a fundamental tension between controlling healthcare costs and ensuring access to timely and appropriate care. The House Committee on Energy and Commerce is scheduled to hold another hearing on healthcare affordability in June, where prior authorization is expected to be a key topic of discussion.
addressing this issue will require a collaborative effort from lawmakers, insurers, and healthcare providers. A more streamlined, transparent, and patient-centered approach to prior authorization is essential to ensure that patients receive the care they need, when they need it. Share your experiences with prior authorization and let your representatives know that this issue matters to you.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or financial advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
